基本信息
浏览量:62
职业迁徙
个人简介
In her role as the Director of Operations, Dr. Dobrovolskaia leads the NCL operations to provide preclinical nanoparticle characterization services to the nanotechnology research community, advance the translation of promising nanotechnology concepts from bench to the clinic, and contribute to the education of the next generation of scientists in the field of preclinical development of nanotechnology-based products, the activities emphasized in the NCL mission. She also directs the performance of Immunology, Client Relations and Administrative sections of the NCL. Closely integrated functioning of these sections plays a critical role in advancing the NCL’s key strategic goals, and in supporting the missions of the Frederick National Laboratory for Cancer Research.
研究兴趣
论文共 172 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Methods in molecular biology (Clifton, N.J.) (2024): 161-169
Methods in molecular biology (Clifton, N.J.) (2024): 193-207
Methods in molecular biology (Clifton, N.J.) (2024): 153-159
Methods in molecular biology (Clifton, N.J.) (2024): 129-135
Methods in Molecular Biology Characterization of Nanoparticles Intended for Drug Delivery (2024): 137-143
Methods in molecular biology (Clifton, N.J.) (2024): 145-151
Methods in Molecular Biology Characterization of Nanoparticles Intended for Drug Delivery (2024): 121-127
Methods in molecular biology (Clifton, N.J.) (2024): 293-298
Methods in molecular biology (Clifton, N.J.) (2024): 101-108
Methods in molecular biology (Clifton, N.J.) (2024): 185-192
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn